Faculty profile

Jean Wang

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Jean Wang

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
106 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 ONTARIO), most recently in 2014.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

321

Publications

17,394

Citations

100

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.
Haematologica · 2026 · senior author
Transposable elements shape stemness in normal and leukemic hematopoiesis.
Nature genetics · 2026
Figure S4 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells
2026

All 321 publications

Latest funding

Discovery of sex-dimorphic leukemia-protective programs embedded in human hematopoietic stem cells
CIHR · 2025 · Co-investigator
$1,591,200
Developing new therapeutic strategies for AML (Acute Myeloid Leukemia)
CIHR · 2016 · Co-investigator
$3,333,379
SIRPαFc: Translating Genomics Research Into a Novel Cancer Immunotherapy
ONTARIO · 2014 · Principal investigator
$1,350,000

All 3 grants and awards

From the 150 most recent of 321 publications.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Murphy T, Zhang B, Zhang T, King I, Capo-Chichi J-M, Gupta V, Maze D, McNamara CJ, Minden MD, Schimmer AD

Haematologica20266 citationsSenior authorOpen Access

DOI: 10.3324/haematol.2025.287777

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Grillo G, Nadorp B, Qamra A, Drylie B, Mitchell A, Arlidge C, Nand A, Takayama N, Murison A, Madani Tonekaboni SA, Kang KK, Arruda A, Wang JCY, Minden MD, Deniz Ö, Boutzen H, Dick JE, Lupien M

Nature genetics20264 citationsOpen Access

DOI: 10.1038/s41588-026-02585-z PMID: 42082719

Figure S4 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Jay M. Gamma, Qiang Liu, Erwan Beauchamp, Aishwarya Iyer, Megan C. Yap, Zoulika Zak, Cassidy Ekstrom, Rony Pain, Morris A. Kostiuk, John Robert Mackey, Joseph M. Brandwein, Jean C. Y. Wang, Luc G. Berthiaume

2026Open Access

DOI: 10.1158/1535-7163.32710870

Figure S2 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710876

Figure S7 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710861

Figure S14 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710879

Figure S8 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710858

Figure S9 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710855

Figure S13 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710882

Figure S6 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

2026Open Access

DOI: 10.1158/1535-7163.32710864

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Jean Wang

Research

Latest papers

Latest funding

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Figure S4 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S2 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S7 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S14 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S8 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S9 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S13 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Figure S6 from Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells

Discovery of sex-dimorphic leukemia-protective programs embedded in human hematopoietic stem cells

Developing new therapeutic strategies for AML (Acute Myeloid Leukemia)

SIRPαFc: Translating Genomics Research Into a Novel Cancer Immunotherapy

Frequent collaborators

John Dick

Mark Minden

Gary Bader

Kerstin Kaufmann

Stephanie Xie

Steven Chan

Aaron Schimmer

Kolja Eppert

Jayne Danska

James Koropatnick

Suzanne Trudel

Cynthia Guidos

Saman Maleki Vareki

Connie Eaves

Tracy Stockley

Peter Zandstra

Mathieu Lupien

Dawn Maze

Paul Spagnuolo

Guri Giaever

Jeffrey Wrana

Vikas Gupta

Sagi Abelson

Ivan Pasic

Igor Novitzky-Basso

Rob Rottapel

Sylvain Baruchel

Dennis Kim

Auro Viswabandya

Rima Al-awar

Hassan Sibai

Wilson Lam